CONMED Corporation (CNMD)

Gross profit margin

Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Gross profit (ttm) US$ in thousands 730,535 743,411 738,820 733,033 716,864 705,928 692,889 676,245 625,932 609,488 590,575 571,245 595,239 585,930 575,577 568,035 547,693 539,085 469,590 460,300
Revenue (ttm) US$ in thousands 1,347,471 1,326,246 1,315,998 1,307,015 1,288,116 1,275,993 1,261,548 1,244,743 1,168,565 1,139,075 1,098,613 1,045,472 1,068,575 1,042,314 1,020,285 1,010,635 989,493 978,501 881,125 862,458
Gross profit margin 54.22% 56.05% 56.14% 56.08% 55.65% 55.32% 54.92% 54.33% 53.56% 53.51% 53.76% 54.64% 55.70% 56.21% 56.41% 56.21% 55.35% 55.09% 53.29% 53.37%

September 30, 2025 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $730,535K ÷ $1,347,471K
= 54.22%


Peer comparison

Sep 30, 2025

Company name
Symbol
Gross profit margin
CONMED Corporation
CNMD
54.22%
Abbott Laboratories
ABT
53.98%
Stryker Corporation
SYK
63.54%